RGT 7.58% 30.5¢ argent biopharma limited

Can we trust in MXC / ERI Management?, page-34

  1. 1,880 Posts.
    lightbulb Created with Sketch. 958

    ‘The Prospectus’ is simply a “Compliance Prospectus”, a requirement of ASIC prior to all RTOS re-listing as new entities with change of interest / business focus.

    I dare say the preamble to this prospectus will read something like the following……………..

    This Prospectus is a re-compliance prospectus for the purposes of satisfying Chapters 1 and 2 of the ASX Listing Rules and to satisfy ASX requirements for re-listing following a change to the nature and scale of the Company’s activities. This is an important document that should be read in its entirety. If you do not understand it you should consult your professional advisers without delay.
    No securities will be issued or sold under this Prospectus.


    This compliance prospectus is a mere formality. It should not delay re-listing and it does not involve any capital raising or subscription / issuing of shares.

    It should be full steam ahead……………….. very soon now!
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
30.5¢
Change
-0.025(7.58%)
Mkt cap ! $14.76M
Open High Low Value Volume
30.0¢ 30.5¢ 30.0¢ $1.48K 4.929K

Buyers (Bids)

No. Vol. Price($)
1 3000 30.0¢
 

Sellers (Offers)

Price($) Vol. No.
34.0¢ 823 3
View Market Depth
Last trade - 15.11pm 30/08/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.